I don’t have live access to current news in this turn, but I can help summarize recent coverage on Pompe disease and related developments if you’d like. If you want the very latest, I can guide you to reliable sources or pull in updates as soon as I have tool access.
What I can provide now:
- A quick overview of recent therapeutic developments for Pompe disease (LOPD and EOPD), including approved therapies, ongoing trials, and notable company activity.
- Suggestions for trusted outlets to monitor for breaking Pompe news (e.g., patient advocacy groups, specialized medical news sites, and regulatory agency updates).
- A plan to track updates tailored to your interests (e.g., specific drugs, trials, or regional regulatory decisions).
Please tell me:
- Are you most interested in drug approvals, clinical trials, regulatory decisions, or patient advocacy/news?
- Do you want a brief summary now or a structured, periodically updated briefing (e.g., weekly)?
Sources
Category archive page for News.
pompediseasenews.comAro Biotherapeutics has launched a Phase 1b clinical trial for ABX1100, a substrate reduction therapy (SRT). This Pompe Empowerment Workshop welcomes patients and their family from Ontario or the Maritimes, for networking, learning and sharing. This Substrate Reduction Therapy drug could be the first pill taken by mouth to treat Pompe disease. The #Pies4Pompe Challenge is an awareness campaign hosted by Canadian Association of Pompe and driven by community and public participation. … One of a...
www.pompecanada.comWelcome to Pompeandyou.com, an educational community that provides information and resources to help you along your journey with Pompe disease.
pompeandyou.comGet the latest news on Pompe disease, its causes, symptoms, diagnosis, and treatments. Hear patient and caregiver voices from our growing Pompe community.
pompediseasenews.compompe day Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. pompe day Blogs, Comments and Archive News on Economictimes.com
economictimes.indiatimes.comThis Substrate Reduction Therapy drug could be the first pill taken by mouth to treat Pompe disease. This Substrate Reduction Therapy drug could be the first pill taken by mouth to treat Pompe disease. One of a handful of gene therapy companies with pipelines that include Pompe disease. Today AVROBIO announced a halt to their programs. Amicus Therapeutics, announces the approval of Opfolda (miglustat) capsules, an enzyme stabilizer of cipaglucosidase alfa, by the European Commission for the...
www.pompecanada.compompe Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. pompe Blogs, Comments and Archive News on Economictimes.com
economictimes.indiatimes.comSpark Therapeutics Stops Its Pompe Program The IPA has been informed that Spark Therapeutics has realigned its portfolio and made the difficult decision to stop its... Author: IPA News July 13, 2024 Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the European Union Amicus Therapeutics announces that the European Commission (EC) has granted approval for Opfolda® (miglustat), an enzyme stabilizer of cipaglucosidase alfa, an...
worldpompe.orgMany people receive the plethora of global news items through Google Alerts, Facebook and other Pompe websites, for example "Pompe Disease News". Posts here will be restricted to significant developme
pompe.uk